Publication | Closed Access

Metformin attenuates vascular pathology by increasing expression of insulin-degrading enzyme in a mixed model of cerebral amyloid angiopathy and type 2 diabetes mellitus

Metabolic SyndromeAlzheimer's DiseaseMixed ModelMedicineInsulin ManagementDiabetesVascular PathologyType 2Vascular BiologyNeurologyNeuroscienceDiabetes MellitusMicrovascular DysfunctionPharmacologyAtherosclerosisInsulin Signaling